Article Text

Download PDFPDF
A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer
  1. R. SRIVANI and
  1. Department of Microbiology and Tumor Biochemistry, Cancer Institute, Adyar, Chennai, India
  1. Address correspondence and reprint requests to: B. Nagarajan, Department of Microbiology and Tumor Biochemistry, Cancer Institute, Adyar, Chennai – 600 020, India. Email: caninst{at}


Interleukin-6 (IL-6) is a multifunctional cytokine with a growth promoting role in cancers. In an attempt to evaluate the prognostic significance of IL-6, we have studied the localization of this cytokine by immunohistochemical methods in normal, premalignant, and invasive cervical cancers. We stained frozen sections with a monoclonal antibody specific for human IL-6 and demonstrated that tumor cells show positivity with high intensity and stromal cells with moderate intensity. T cells and macrophages, components of the stroma that secrete IL-6, were also looked at. While T cells showed a weak positive correlation, CD68-positive macrophages showed significant positive correlation (P < 0.05) with IL-6 positivity in stroma. The patients were followed up for 40 months after treatment with standard radiotherapy regimen and showed residual tumor where pretreatment IL-6 levels were high. Our results suggest its possible candidature as a prognostic indicator of cervical cancer.

  • cancer
  • interleukin-6
  • prognostic significance
  • T cells
  • tumor-associated macrophages
  • uterine cervix

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.